Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Bredt David. Director active across 1 company, notably Rapport Therapeutics, Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 0 buy · 12 sells. Total volume traded: €1.3m. History available since 14 March 2025. The latest transaction was filed on 17 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bredt David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
900 shares@ US$28.02111.7% of flowCommon StockSEC:0001193125-26-059883:0
8,300 shares@ US$26.825515.1% of flowCommon StockSEC:0001193125-26-015350:0
18,000 sharesCommon StockSEC:0001193125-26-002470:0
7,704 shares@ US$29.946918.7% of flowCommon StockSEC:0001193125-25-321142:0
3,156 shares@ US$24.83997.9% of flowCommon StockSEC:0001193125-25-286212:0
7,418 shares@ US$25.732920.8% of flowCommon StockSEC:0001193125-25-241475:0
5,098 shares@ US$23.884116.6% of flowCommon StockSEC:0001193125-25-206203:0
8,300 shares@ US$14.976920.5% of flowCommon StockSEC:0000950170-25-109838:0
8,500 shares@ US$13.995524.8% of flowCommon StockSEC:0000950170-25-096268:0
8,500 shares@ US$11.002626.1% of flowCommon StockSEC:0000950170-25-087897:0
8,500 shares@ US$9.560231.6% of flowCommon StockSEC:0000950170-25-074409:0
8,500 shares@ US$9.565931.4% of flowCommon StockSEC:0000950170-25-054819:0
8,500 shares@ US$10.847737.0% of flowCommon StockSEC:0000950170-25-040447:0
About Bredt David
Bredt David is a declarant linked to Rapport Therapeutics, Inc., where he is Chief Scientific Officer. He has 4 filings in total, and across the 4 recent filings available, all are sales for a total of EUR 310505 between 2025-03-17 and 2025-06-18.